Hormone Replacement Therapy (HRT)
Hormone Replacement Therapy Improves Bone Mineral Loss After Salpingo-oophorectomy for Ovarian CancerApril 11, 2016
In patients who undergo risk-reducing salpingo-oophorectomy, BMD screenings are underutilized in spite of the prevalence of bone mineral loss in this population. Hormone replacement therapy can address BMD loss in these women.
The impact of hormone replacement therapy (HRT) use on breast cancer risk varies according to patient race/ethnicity, body mass index (BMI), and breast density, researchers have learned.
HRT-linked risk up for white, Asian, Hispanic women; for low/normal BMI and dense breasts.
ONS Connections: Pretreatment depression, anxiety, and poor physical functioning associated with non-adherence to hormonal therapy in breast cancer patientsNovember 18, 2012
Taking a lower percentage of prescribed doses of hormonal therapy was associated with higher pre-therapy levels of depression and anxiety and with poorer physical functioning.
Risk increased with estrogen, estrogen progesterone; no increase in fatal breast cancer.
Women who used estrogen after hysterectomy appear to be nearly 25% less likely to develop breast cancer and nearly 63% less likely to die from it.
Discontinuing hormone therapy may lead to tumor regression in breast cancer, indicate the results of a new study.
The use of estrogen-only after hysterectomy lowers the risk of breast cancer, but largely in groups already at low risk of breast cancer.
The first drop in mammography rates since 1987 among age-eligible women occurred in 2005, and at least partial blame can be pinned on the decline in the use of hormone therapy.
Postmenopausal women who use estrogen do not increase their risk for lung cancer mortality, according to a study published in The Journal of the National Cancer Institute (2010 Aug 13. [Epub ahead of print]).
Breast cancer risk increases with long-term use of hormone therapies, according to a study that analyzed the California Teachers Study.
Breast cancer risk in postmenopausal women varies depending on the type of progestin used in hormone replacement therapy, according to a study published in Cancer Prevention Research (2010 Aug 10 [Epub ahead of print]).
Short-term hormonal therapy increases overall survival in patients with prostate cancer, according to a study presented at the 2010 Genitourinary Cancers Symposium.
GPs should advise women to continue taking HRT, despite claims linking it to breast cancer, according to an expert on the menopause.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino Women
- Live-streamed Videos Address End-of-Life Planning, Decision-making
- Metastatic Disease Linked to Patients Reporting Diminished QoL
- History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer Diagnosis
- Mammographically Occult Contralateral Breast Cancer Detection is Effective With Preoperative MRI
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|